/MMSI
Merit Medical Systems, Inc.
MMSI • NASDAQMMSI • NASDAQ • Healthcare
$68.17-2.73%-1.91
$68.17-2.73%(-1.91)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
96Low Risk
Momentum
8Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
48.7%▲1.3pp
Revenue after COGS
Operating
12.2%▲0.7pp
After operating expenses
Net
8.5%▼0.4pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
40.6
Price vs earnings
EV/EBITDA
17.1
Enterprise value
FCF Yield
4.1%
Cash generation
Earnings Yield
2.5%
Inverse of P/E
Capital Efficiency
6
GoAI Quality ScoreWeak
ROEReturn on Equity
8.1%Fair
ROAReturn on Assets
4.8%Fair
ROICReturn on Invested Capital
5.7%Fair
Financial Health
Current RatioHealthy
4.34
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.35x
Debt repayment capacity (<3x)
Income QualityStrong
2.31
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.52B | $1.36B | $1.26B | $1.15B | $1.07B |
| Gross Profit | $738.27M | $643.33M | $583.87M | $519.10M | $485.33M |
| Gross Margin | 48.7% | 47.4% | 46.4% | 45.1% | 45.2% |
| Operating Income | $184.72M | $155.69M | $123.94M | $87.56M | $60.92M |
| Net Income | $128.49M | $120.36M | $94.41M | $74.52M | $48.45M |
| Net Margin | 8.5% | 8.9% | 7.5% | 6.5% | 4.5% |
| EPS | $2.17 | $2.07 | $1.64 | $1.31 | $0.86 |
Average Price Target
$100.67▲ 47.7% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Merit Medical Systems, Inc., the average price target is $100.67, with a high forecast of $108.00 and a low forecast of $78.00. The average price target represents a 47.7% increase from the current price of $68.17.
Highest
$108.00
Average
$100.67
Lowest
$78.00
Rating Distribution
Strong Buy
0
0%
Buy
10
77%
Hold
2
15%
Sell
1
8%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Wells Fargo▼ Downgrade
Overweight→Equal Weight
2026-02-26Barrington Research● Maintain
Outperform
2026-02-25Needham● Maintain
Buy
2026-02-25Piper Sandler● Maintain
Overweight
2026-02-18Needham● Maintain
Buy
2026-01-09Canaccord Genuity● Maintain
Buy
2025-12-17Wells Fargo● Maintain
Overweight
2025-11-14Canaccord Genuity● Maintain
Buy
2025-11-14Barrington Research● Maintain
Outperform
2025-11-14Piper Sandler● Maintain
Overweight
2025-10-31Earnings History & Surprises
BEAT RATE
100%
Last 18 quarters
AVG SURPRISE
+15.0%
EPS vs Estimate
BEATS / MISSES
18/0
Last 18 quarters
LATEST EPS
$1.04
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+9.0%
$1.04 vs $0.95
Q4 '25
+12.2%
$0.92 vs $0.82
Q3 '25
+17.4%
$1.01 vs $0.86
Q2 '25
+14.8%
$0.86 vs $0.75
Q1 '25
+13.4%
$0.93 vs $0.82
Q4 '24
+7.5%
$0.86 vs $0.80
Q3 '24
+4.5%
$0.92 vs $0.88
Q2 '24
+8.5%
$0.77 vs $0.71
Q1 '24
+5.2%
$0.81 vs $0.77
Q4 '23
+15.4%
$0.75 vs $0.65
Q3 '23
+8.0%
$0.81 vs $0.75
Q2 '23
+16.4%
$0.64 vs $0.55
No investor questions available.
Latest News
No news available